NCT06951737View on ClinicalTrials.gov

Evaluation Of The Effect Of SGLT-2 Inhibitors On Atrial Fibrillation Recurrence In Diabetic Patients

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

October 2, 2022

Primary Completion Date

April 2, 2024

Study Completion Date

October 2, 2024

Conditions
Diabetes MellitusAtrial Fibrillation (AF)
Trial Locations (1)

Unknown

Bursa Yüksek İhtisas Hastanesi, Bursa

All Listed Sponsors
lead

Bursa Postgraduate Hospital

OTHER